Evaluation of Abbott Fourth Generation HIV Antigen and Antibody Assays

2006 ◽  
Vol 26 (1) ◽  
pp. 39-44 ◽  
Author(s):  
Hee Jung Kang ◽  
Kyeong Ha Yoo ◽  
Han Sung Kim ◽  
Hyoun Chan Cho
2015 ◽  
Vol 62 ◽  
pp. 92-97 ◽  
Author(s):  
Dramane Kania ◽  
Tam Nguyen Truong ◽  
Ana Montoya ◽  
Nicolas Nagot ◽  
Philippe Van de Perre ◽  
...  

2019 ◽  
Vol 65 (10/2019) ◽  
Author(s):  
Hui Han ◽  
Yanhua Huang ◽  
Qian Dong ◽  
Yunxiu Huang ◽  
Jianqiang Lu ◽  
...  

2018 ◽  
Vol 56 (8) ◽  
Author(s):  
Mars Stone ◽  
John Bainbridge ◽  
Ana M. Sanchez ◽  
Sheila M. Keating ◽  
Andrea Pappas ◽  
...  

ABSTRACTDetection of acute HIV infection is critical for HIV public health and diagnostics. Clinical fourth-generation antigen (Ag)/antibody (Ab) combination (combo) and p24 Ag immunoassays have enhanced detection of acute infection compared to Ab-alone assays but require ongoing evaluation with currently circulating diverse subtypes. Genetically and geographically diverse HIV clinical isolates were used to assess clinical HIV diagnostic, blood screening, and next-generation assays. Three-hundred-member panels of 20 serially diluted well-characterized antibody-negative HIV isolates for which the researchers were blind to the results (blind panels) were distributed to manufacturers and end-user labs to assess the relative analytic sensitivity of currently approved and preapproved clinical HIV fourth-generation Ag/Ab combo or p24 Ag-alone immunoassays for the detection of diverse subtypes. The limits of detection (LODs) of virus were estimated for different subtypes relative to confirmed viral loads. Analysis of immunoassay sensitivity was benchmarked against confirmed viral load measurements on the blind panel. On the basis of the proportion of positive results on 300 observations, all Ag/Ab combo and standard sensitivity p24 Ag assays performed similarly and within half-log LODs, illustrating the similar breadth of reactivity and diagnostic utility. Ultrasensitive p24 Ag assays achieved dramatically increased sensitivities, while the rapid combo assays performed poorly. The similar performance of the different commercially available fourth-generation assays on diverse subtypes supports their use in broad geographic settings with locally circulating HIV clades and recombinant strains. Next-generation preclinical ultrasensitive p24 Ag assays achieved dramatically improved sensitivity, while rapid fourth-generation assays performed poorly for p24 Ag detection.


2019 ◽  
Vol 101 (2) ◽  
pp. 285-286
Author(s):  
Adedotun A. Adetunji ◽  
Moses O. Adewumi ◽  
Obaro S. Michael ◽  
Samuel A. Fayemiwo ◽  
Adesola Ogunniyi ◽  
...  

IDCases ◽  
2020 ◽  
Vol 21 ◽  
pp. e00886
Author(s):  
Matthew A. Robinson ◽  
Shravya R. Nagurla ◽  
Tiffany R. Noblitt ◽  
Nouf K. Almaghlouth ◽  
Maher M. Al-rahamneh ◽  
...  

2010 ◽  
Vol 17 (10) ◽  
pp. 1642-1644 ◽  
Author(s):  
Sinyoung Kim ◽  
Jong-Han Lee ◽  
Jun Yong Choi ◽  
June Myung Kim ◽  
Hyon-Suk Kim

ABSTRACT We retrospectively analyzed the performance of the Architect HIV antigen/antibody (Ag/Ab) combination assay in a tertiary health care center with a situation of low HIV prevalence. The specificity and positive predictive value (PPV) were 99.78% and 31.21%, respectively. However, the specificity and PPV could increase to 99.99% and 89.70% using an arbitrary cutoff value.


2011 ◽  
Vol 42 (9) ◽  
pp. 523-535 ◽  
Author(s):  
Frank H. Wians ◽  
Holly A. Moore ◽  
Donna Briscoe ◽  
Kathy M. Anderson ◽  
Pamela S. Hicks ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document